Chief Financial Officer
Mr. Rimac joins Chrono from Aldea Pharmaceuticals where he was Chief Financial Officer. Prior to Aldea Tony served as C.F.O. of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS), a neurology focused company and Aerovance, Inc., a privately held biopharmaceutical company, spun off from Bayer Pharmaceuticals in 2004, focused on development and commercialization of clinical-stage products for respiratory and allergic diseases. Tony has over 25 years of broad operating and finance experience including 18 years in the life sciences industry ranging from biotech, specialty pharmaceuticals, drug delivery and medical devices and has raised in excess of $400M in equity and debt capital and partnership financing.
Tony received an MBA from Santa Clara University's Graduate School of Business Administration, and a B.A. in Business Economic – Accounting Emphasis from the University of California at Santa Barbara. Tony is also a licensed Certified Public Accountant in the State of California (inactive).